関連文献

Relationship of urinary liver-type fatty acid-binding protein with cardiovascular risk factors in the Japanese population without chronic kidney disease: Sasayama study.

BMC Nephrol. 2021doi: 10.1186/s12882-021-02398-8. PubMed

Preliminary study of urinary excretion of liver-type fatty acid-binding protein in a cat model of chronic kidney disease.

Can J Vet Res. 2021PubMed

Evaluation of urinary L-FABP as an early marker for diabetic nephropathy in type 2 diabetic patients.

J Med Biochem. 2020doi: 10.2478/jomb-2019-0037. PubMed

Liver-type fatty acid-binding protein and neutrophil gelatinase-associated lipocalin in cats with chronic kidney disease and hyperthyroidism.

J Vet Intern Med. 2021doi: 10.1111/jvim.16074. PubMed

Predictive value of novel biomarkers for chronic kidney disease among workers occupationally exposed to silica.

Toxicol Ind Health. 2021doi: 10.1177/0748233721990304. PubMed

Urinary liver-type fatty acid-binding protein is a predictor of mortality in individuals with type 2 diabetes.

Diabet Med. 2021doi: 10.1111/dme.14527.PubMed

Renoprotective effect of GLP-1 receptor agonist, liraglutide, in early-phase diabetic kidney disease in spontaneously diabetic Torii fatty rats.

Clin Exp Nephrol. 2021doi: 10.1007/s10157-020-02007-2.PubMed

Urinary Liver-type Fatty Acid-Binding Protein Predicts Residual Renal Function Decline in Peritoneal Dialysis Patients.

Med Sci Monit. 2020PubMed

Novel Urinary Biomarkers and Chronic Kidney Disease After Coronary Angiography: A Prospective Case-Controlled Study.

Open Access Maced J Med Sci. 2020OAMJMS

Longitudinal kidney injury biomarker trajectories in children with obstructive uropathy.

Pediatr Nephrol. 2020PubMed